MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Effect of COVID-19 Pandemic on Utilization of Parkinson’s Medications in Saudi Arabia: A Repeated Cross-Sectional Study

    K. Orayj (Abha, Saudi Arabia)

    Objective: This study aims to examine the effects of the pandemic on the patterns of medication usage for Parkinson’s Disease (PD) in Saudi Arabia. Background:…
  • 2025 International Congress

    Platelets Lipidome as Potential Biomarker of Parkinson’s Disease

    G. Uras, S. Lucas-Del-Pozo, V. Lentini, F. Fierli, S. Koletsi, D. Hughes, A. Schapira, . (London, United Kingdom)

    Objective: The aim of this proejct is to identify novel biomarkers of Parkinson's disease diagnosis and progression, with a focus on GBA-PD. Background: Our previous…
  • 2025 International Congress

    Phase 1 and 1b Pharmacodynamic Data Support Central Modulation of Lysosomal Pathways With BIIB122/DNL151, a LRRK2 Kinase Inhibitor: Insights for the LUMA Trial

    K. Fraser, A. Lang, L. Kalia, R. Hauser, J. Greenamyre, Y. Moroishi, J. Kluss, B. Hersh, K. Ferber, R. Maciuca, C. Paián-Ruiz, R. Llorens-Arenas, D. Jennings, S. Huntswork-Rodriguez, D. Graham (Tampa, USA)

    Objective: Evaluate the effects of BIIB122/DNL151 treatment on CSF levels of pRab10, a biomarker of CNS LRRK2 modulation, in a Phase 1 study in healthy…
  • 2025 International Congress

    Identification of Rigidity in Parkinson’s Disease Using Wearable Technology

    P. Sharma, C. Sotirakis, J. Huxley, J. Fitzgerald, C. Antoniades (Oxford, United Kingdom)

    Objective: To evaluate the capacity of upper limb kinematic measures, collected using wearable technology, in (a) capturing clinical rigidity in Parkinson’s disease (PD) and (b)…
  • 2025 International Congress

    1H-NMR and UPLC/MS Metabolomics Identify Disrupted Homeostasis of Energy, Amino Acids, and Glutathione Metabolism as Serum Signatures in Parkinson’s Disease Patients

    A. Imarisio, J. Gervasoni, C. Marino, L. Santucci, E. Napolitano, T. Nuzzo, I. Yahyavi, M. Avenali, M. Cicchinelli, C. Galandra, M. Picascia, M. Grimaldi, C. Pacchetti, F. Errico, AM. D'Ursi, A. Urbani, A. Usiello, EM. Valente (Rome, Italy)

    Objective: We sought to identify a signature distinctive of Parkinson’s disease (PD) through two independent metabolomics approaches. Background: A recent meta-analysis showed a considerable inconsistency…
  • 2025 International Congress

    Interpretable voice-based detection of Parkinson’s disease using language-independent graph neural networks

    S. Patel, C. Antoniades, J. Fitzgerald, O. Bredemeyer (Oxford, United Kingdom)

    Objective: To develop a robust, interpretable, and language-independent tool for voice-based detection of Parkinson’s disease (PD) using graph neural networks (GNNs), demonstrating superior cross-linguistic generalization…
  • 2025 International Congress

    Evaluation Of Visual Perception Using Noise Pareidolia Test in Bangladeshi Patients with Parkinson’s disease.

    T. Zannat, E. Camboe, K. Dey, A. Zirra, A. Haque, D. Mair, S. Waters, C. Marshall, N. Mukadam, R. Weil, A. Noyce, A. Habib (Dhaka, Bangladesh)

    Objective: To evaluate the prevalence of visual misperception in patients with PD (PwP) in comparison with healthy control (HC) and its association with visual hallucinations.…
  • 2025 International Congress

    Ameliorating effect of linalool on anxiety disorders in Parkinson’s mice and related mechanisms

    F. Lou, M. Li (Shenyang, China)

    Objective: The aim of this study was to verify the ameliorating effect of linalool(LIN) on anxiety-related affective disorders and the associated receptors in a MPTP…
  • 2025 International Congress

    Caution in the creation of Parkinson’s disease cognitive composites

    D. Gonzalez, A. Karstens, J. Fleisher, S. Patel, C. Goetz (Chicago, USA)

    Objective: To evaluate the structural validity of new cognitive composites in Parkinson’s disease (PCCs). Background: PCCs created from constituent tasks are promising in their single-index…
  • 2025 International Congress

    Unravelling The Relationship Between Autonomic Nervous System And Anxiety In People With Parkinson’s Disease

    L. Ricciardi, A. Fanciulli, F. Cucinotta, B. Ishahara, I. Cociasu, F. Baig, E. Pereira, M. Hart, F. Morgante, E. Makovac (London, United Kingdom)

    Objective: To investigate objective cardiovascular measures in relation to anxiety in PD patients, and the structural neural changes underlying this putative interaction.T Background: Anxiety and…
  • « Previous Page
  • 1
  • …
  • 11
  • 12
  • 13
  • 14
  • 15
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • #24970 (not found)
  • Comorbid Normal Pressure Hydrocephalus with Parkinson’s disease: a call for clinical awareness
  • Clonazepam as a cure or a cause? : Withdrawal Emergent Syndrome
  • Common mistakes in the MoCA test in patients with Parkinson’s Disease in Kyrgyzstan
  • Welcome to the MDS Abstracts Site
  • Effect of marijuana on Essential Tremor: A case report
  • Advanced Search
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley